| [1] |
Kuhl CK, Mielcarek P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesion?. Radiology, 1999, 211(1): 101-110.
|
| [2] |
de Azambuja E, Cardoso F, de Castro G Jr, et al. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12155 patients. Br J Cancer, 2007, 96(10): 1504-1513.
|
| [3] |
Viale G, Regan MM, Mastropasqua MG, et al. Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Natl Cancer Inst, 2008, 100(3): 207-212.
|
| [4] |
Avril N, Menzel M, Dose J, et al. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med, 2001, 42(1): 9-16.
|
| [5] |
Eberlein TJ. Current management of carcinoma of the breast. Ann Surg, 1994, 220(2): 121-136.
|
| [6] |
贾臻, 章英剑, 胡夕春.乳腺癌ER、PR及Her-2的表达状态与18F-FDG摄取的研究进展.中国癌症杂志, 2011, 21(10): 807-811.
|
| [7] |
徐慧, 贾文霄, 周梅.乳腺癌动态增强MRI表现与病理、分子预后指标的相关性分析.中国医学影像杂志, 2011, 19(2): 121-128.
|
| [8] |
王美芹, 董珉, 徐新宇.乳腺癌MRI表现与免疫组化相关性的初步研究.医学影像学杂志, 2010, 20(8): 1130-1133.
|
| [9] |
舒虹, 梅金红, 谭亚敏, 等.乳腺癌MRI形态学表现与ER、PR、CerbB-2及Ki-67相关性研究.实用临床医学, 2011, 12(8): 97-100.
|